|
|
|||
| |||||||||||||||||||||||||||||||
In the past decade, there have been considerable advances in our understanding of the biology of breast cancer and in its treatment. The primary treatment of breast cancer is complex and multidisciplinary, involving surgeons, radiation and medical oncologists, nurses, and social workers. As long-term follow-up data from clinical trials have become available and prognostic factors have been better defined, the heterogeneity of breast cancer as a disease has become increasingly apparent. At the same time, patients with breast cancer have become better informed about treatments and require a more detailed explanation of their treatment options (e.g., mastectomy vs. breast-conserving treatment
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |